Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
出版年份 2016 全文链接
标题
Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
作者
关键词
-
出版物
Acta Physiologica
Volume 219, Issue 1, Pages 138-151
出版商
Wiley
发表日期
2015-12-18
DOI
10.1111/apha.12644
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice
- (2016) Sokrates Stein et al. Aging-US
- Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor
- (2015) Haruo Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions
- (2015) Suparna Ghosh et al. BIOCHEMICAL PHARMACOLOGY
- Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies
- (2015) Hongmei Zhu et al. DIABETOLOGIA
- MicroRNA Signature and Cardiovascular Dysfunction
- (2015) Gnanapragasam Arunachalam et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
- (2015) Mustafa Kinaan et al. MEDICAL PRINCIPLES AND PRACTICE
- Endothelial AMP-Activated Protein Kinase Regulates Blood Pressure and Coronary Flow Responses Through Hyperpolarization Mechanism in Mice
- (2014) B. Enkhjargal et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Metformin Protects Endothelial Function in Diet-Induced Obese Mice by Inhibition of Endoplasmic Reticulum Stress Through 5′ Adenosine Monophosphate–Activated Protein Kinase–Peroxisome Proliferator–Activated Receptor δ Pathway
- (2014) Wai San Cheang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Diabetes and cancer: 5years into the recent controversy
- (2014) Ellena Badrick et al. EUROPEAN JOURNAL OF CANCER
- Ghrelin Receptor Regulates Appetite and Satiety during Aging in Mice by Regulating Meal Frequency and Portion Size but Not Total Food Intake
- (2014) Ligen Lin et al. JOURNAL OF NUTRITION
- The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
- (2014) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
- (2014) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Initial Choice of Oral Glucose-Lowering Medication for Diabetes Mellitus
- (2014) Seth A. Berkowitz et al. JAMA Internal Medicine
- Cardiovascular impact of drugs used in the treatment of diabetes
- (2014) Chris R. Triggle et al. Therapeutic Advances in Chronic Disease
- Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1
- (2013) Gnanapragasam Arunachalam et al. BRITISH JOURNAL OF PHARMACOLOGY
- MicroRNAs and Metabolism Crosstalk in Energy Homeostasis
- (2013) Olivier Dumortier et al. Cell Metabolism
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- The latest pharmacotherapy options for type 1 diabetes
- (2013) Johnny Ludvigsson EXPERT OPINION ON PHARMACOTHERAPY
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- Metformin reduces vascular endothelial dysfunction caused by an acute glucose load in patients with hypertension
- (2012) Ting-Xing Zhang et al. BLOOD PRESSURE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- MicroRNAs in Vascular and Metabolic Disease
- (2012) Anna Zampetaki et al. CIRCULATION RESEARCH
- MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression
- (2012) Tsuyoshi Tabuchi et al. CLINICAL SCIENCE
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Activation of the AMP-Activated Protein Kinase by Eicosapentaenoic Acid (EPA, 20:5 n-3) Improves Endothelial Function In Vivo
- (2012) Yong Wu et al. PLoS One
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses
- (2012) B. Hemmingsen et al. BMJ-British Medical Journal
- Calorie restriction and resveratrol in cardiovascular health and disease
- (2011) Vernon W. Dolinsky et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- SIRT1: roles in aging and cancer
- (2011) Eun-Joo Kim et al. BMB Reports
- Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
- (2011) Ben-Xu Tan et al. CANCER
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia
- (2011) Andrea Caporali et al. CIRCULATION
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
- (2011) K. J. Lipska et al. DIABETES CARE
- Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration
- (2011) S. Larsen et al. DIABETOLOGIA
- Role of microRNAs in endothelial inflammation and senescence
- (2011) Bing Qin et al. MOLECULAR BIOLOGY REPORTS
- AMPK and SIRT1: a long-standing partnership?
- (2010) Neil B. Ruderman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells
- (2010) Issam Ben Sahra et al. Autophagy
- SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol
- (2010) Gnanapragasam Arunachalam et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
- (2010) Xinguo Hou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-34a regulation of endothelial senescence
- (2010) Takashi Ito et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells
- (2010) Yi Zu et al. CIRCULATION RESEARCH
- AMPK-dependent Repression of Hepatic Gluconeogenesis via Disruption of CREB·CRTC2 Complex by Orphan Nuclear Receptor Small Heterodimer Partner
- (2010) Ji-Min Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS
- (2010) Chris R. Triggle et al. Journal of the American Society of Hypertension
- Endothelial dysfunction in diabetes: multiple targets for treatment
- (2010) Hong Ding et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Shear stress, SIRT1, and vascular homeostasis
- (2010) Z. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
- (2009) Beate Fisslthaler et al. CIRCULATION RESEARCH
- AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633
- (2009) Zhen Chen et al. CIRCULATION RESEARCH
- MicroRNAs As Novel Regulators of Angiogenesis
- (2009) Yajaira Suárez et al. CIRCULATION RESEARCH
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- NO Targets SIRT1
- (2008) Michael Potente et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cilostazol Inhibits Oxidative Stress–Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial Cells
- (2008) Hidetaka Ota et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
- (2008) Fan Lan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started